Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Sells Small-Molecule Antibiotics To Pfizer But Still Investing In R&D

Antibiotics

Related Content

Antibiotic Market Snapshot: In Exchange For Higher Prices, More Value

Jan 14 2013

Under Pressure: Can Merck Show Cubist Is Worth $9.5 Billion Without <em>Cubicin</em>?

Dec 15 2014

AstraZeneca Will Establish Antibiotic Subsidiary With $40 Million

Mar 02 2015

AstraZeneca Straddles The Fence On Antibiotics; Is It About To Fall Off?

Oct 21 2014

AZ's Zavicefta Gains EU Positive Opinion For “Superbug” Infections

Apr 29 2016

AstraZeneca’s Business Development Head Grady Outlines Strategy Mix

Aug 15 2016

Related Companies

AstraZeneca PLC

Pfizer Inc.

Medivation, Inc.

Entasis Therapeutics Holdings Inc.

Merck & Co., Inc.

Cubist Pharmaceuticals, Inc.

Allergan plc

Additional Topics

United Kingdom Europe Deals Companies Strategy Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window